Chiral Pharma, Cytodyn Inc. COVID-19 Drug to Secure FDA Approval
Chiral Pharma Corporation, a subsidiary of New Marketlink Pharmaceutical Corporation (NMPC) and a frontrunner in the anti-rabies vaccine market is working with CytoDyn Inc., a US-based biotechnology company focused on…